Skip to main content
. Author manuscript; available in PMC: 2024 Feb 13.
Published in final edited form as: Annu Rev Pharmacol Toxicol. 2019 Jul 5;60:311–331. doi: 10.1146/annurev-pharmtox-010919-023459

Figure 2.

Figure 2

The impact of genetic variants on metabolizer status. Due to genetic differences, the functional activity of a drug metabolism enzyme may be absent, decreased, normal, or increased. Depending on the combination of alleles present, each individual can be classified regarding their functional status for each drug metabolic enzyme as a poor, intermediate, normal, rapid, or ultrarapid metabolizer.